A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection
NCT03258502
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG:
RV521
DRUG:
Placebo
Sponsor
Pfizer